TSE:4528Pharmaceuticals
Ono Pharmaceutical (TSE:4528) Valuation Spotlight as PRISM BioLab Collaboration Achieves Drug Discovery Milestone
Ono Pharmaceutical (TSE:4528) and PRISM BioLab have reached a key milestone in their oncology research collaboration. PRISM received a milestone payment as their joint efforts, using PRISM's PepMetics platform, advanced potential clinical candidates.
See our latest analysis for Ono Pharmaceutical.
Ono Pharmaceutical’s collaboration success comes after several expansion moves, including opening a new European office, as investor optimism continues to build. The stock’s share price has surged...